Tue, Apr 06, 2021 page11

• Record-setting Asian IPO boom likely to taper off

  • Bloomberg
  • • 
    • 
    • 

  As in the US, initial public offering (IPO) activity in Asia has had its strongest start to a year, but the frenzy for new shares is likely to taper off as demand falls back in the next few months.

  Asian companies, like their global peers, notched their best first quarter for listings ever, thanks to a flood of liquidity during the COVID-19 pandemic, low interest rates and rallying stock markets.

  Asian firms raised US$49.3 billion through IPOs at home and abroad — a 154 percent jump over the same period last year, data compiled by Bloomberg showed.

  

  Baidu Inc chairman and CEO Robin Li, center, attends an event at the firm’s headquarters in Beijing on March 23 marking its listing on the Hong Kong Stock Exchange.

  Photo: Reuters

  IPOs globally raised an unprecedented US$215 billion, with almost half of that haul coming from the record wave of issuances by special-purpose acquisition companies (SPAC) in the US.

  Now, a global rotation out of highly valued technology and healthcare stocks that have dominated market activity, as well as fading excitement around SPACs in the US, is clouding the outlook for new deals.

  “Inevitably, there is a mark to market of comparable valuations,” said William Smiley, cohead of equity capital markets at Goldman Sachs Group Inc in Asia ex-Japan. “In terms of our pipeline, there hasn’t been any significant impact from the recent rotation, but opportunistic issuance may have decelerated.”

  Asia’s IPO space faces an added challenge — the travails of Chinese technology firms, which dominate fundraising in the region.

  These companies are facing a crackdown against monopolistic practices at home and are also in focus as US-China tensions rise. For instance, the US last month moved forward with a law that could result in Chinese firms that do not comply with US auditing standards being removed from stock exchanges in the US.

  The red flags are already there, with the investor mania seen earlier this year for deals like the one by Chinese TikTok rival Kuaishou Technology (快手) starting to die down.

  Chinese fintech company Bairong Inc (百融雲創), which raised US$507 million, delivered the worst debut in three years among Hong Kong IPOs valued at more than US$500 million when the shares fell 16 percent on Wednesday last week.

  US-listed Chinese search giant Baidu Inc (百度) and streaming service Bilibili Inc (嗶哩嗶哩) last month raised a combined US$5.7 billion through secondary listings in Hong Kong, but had lackluster debuts.

  In contrast, investors were seen scrambling for a piece of Kuaishou’s US$6.2 billion Hong Kong IPO, the biggest listing globally so far this year, and South Korean e-commerce giant Coupang Inc’s US$4.6 billion float.

  That said, muted investor appetite for listings is not affecting other hopeful companies.

  Online music company Tencent Music Entertainment Group (騰訊音樂娛樂), microblogging service Sina Weibo Corp (微博) and online travel service Trip.com Group Ltd (攜程) are among US-traded Chinese companies seeking so-called “homecoming” listings in Hong Kong.

  These secondary listings, seen as a hedge against China-US tensions, last year raised US$17 billion in Hong Kong and have amassed US$6.4 billion so far this year.

  “The secondary listing trend will continue, but what should be interesting to see is whether new issuers who ultimately want to get to a dual listing, perhaps consider seeking a dual primary listing in Hong Kong and the US from the start, rather than doing a primary US listing, waiting two years and then coming to Hong Kong for the secondary listing,” said Francesco Lavatelli, head of equity capital markets for Asia-Pacific at JPMorgan Chase & Co.

  Technology and healthcare firms make up the bulk of the listing pipeline in Asia, bankers said, even without the “homecoming” cohort, many of whom opted for US listings because of the investor base’s greater familiarity with new economy stocks.

  Among them is healthcare start-up WeDoctor (微醫), which is planning a multibillion Hong Kong IPO and Chinese start-up Full Truck Alliance Group (滿幫集團), which is looking into a US$1 billion US listing.

  “The pipeline remains quite robust, but is centered around tech and growth stocks, which are obviously seeing a little bit of a re-rating,” said Tucker Highfield, cohead of equity capital markets for Asia-Pacific at Bank of America Corp. “The thesis of good companies being able to buck the trend of volatility will continue and there’s capital available.”

  Ultimately, less frothy markets and a cooling of the IPO investor mania might actually be welcome.

  “Entering a more balanced market environment isn’t a bad thing. It can extend the issuance cycle and work to keep excesses in check,” Smiley said. “If there is going to be correction, you want it to be fast — a prolonged downturn kills issuance.”
• Most Popular

  • 1

    TSMC cannot make 2nm chips abroad now: MOEA

  • 2

    Videos about Taiwan upset China: source

  • 3

    Taiwan in Time: The rise and fall of Taipei’s sky bridges

  • 4

    Potential tropical storm could affect Taiwan: CWA

  • 5

    First new MRT line train arrives